Published: Mar 16, 2021
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE)
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it will host a Virtual Rare Disease Forum on Tuesday, March 23
rd, 2021 from 1:00pm to 3:00pm ET. The event will highlight Applied Therapeutics’ development programs in Galactosemia, SORD Deficiency, and PMM2-CDG. The agenda for the event will include:
Update on ACTION-Galactosemia Clinical Development Program
Overview of SORD Deficiency, presented by Stephan L. Züchner, MD, PhD, Professor and Department Chair of Human Genetics at the University of Miami Miller School of Medicine
Applied Therapeutics to Host Virtual Rare Disease Forum globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, Feb. 04, 2021 (GLOBE NEWSWIRE) National law firm Barr Law Group is investigating the actions of the officers and board of directors of NantKwest, Inc., Pluralsight, Inc., JELD-WEN Holding, Inc., and Applied Therapeutics, Inc. If you are a current owner of shares of any of these stocks, contact leo@barrlaw.com or call (619) 400-4966. NantKwest, Inc. (NASDAQ: NK) Merger Accused of Misleading Investors Barr Law Group is investigating NantKwest, Inc. regarding possible breaches of fiduciary duties and other violations of law related to its merger with ImmunityBio. Under the terms of the agreement, ImmunityBio shareholders will receive a fixed exchange ratio of 0.8190 shares of NantKwest for each share of ImmunityBio owned. To learn more about this investigation and your rights, visit: http://barrlaw.com/investor-contact. Representation is contingency based, no out of pocket costs. Pluralsight, Inc. (NASDAQ: PS) Merger Accused of Misleading Investors Barr Law Group announces th
Edelman; FTI Consulting; Sard Verbinnen; Bevel; Yuqing Liu/Business Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Financial communications is flourishing as corporations, private equity, hedge funds, and other investment managers scramble for help managing high-stakes situations, activist shareholders, investor relations, and more.
Business Insider identified 15 of the most-sought financial PR pros working today through reporting, nominations, and publicly available information.
They were chosen based on factors like assignments they ve handled, the caliber of their clients, and revenue growth.
Financial communications has thrived in the pandemic as companies scramble for help fending off shareholder activists, dealing with mergers and acquisitions, and creating SPACs, or special purpose acquisition companies.
Chief Medical Officer of Applied Therapeutics Inc. (NASDAQ:APLT), Perfetti Riccardo, sells 465 shares worth $9,514
According to Applied Therapeutics Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 09 09:55 PM, company Chief Medical Officer, Perfetti Riccardo disclosed selling 465 shares at a cost of $20.46. At the time of this transaction (Dec 09), this trade was worth $9,514 in total. As of Dec 09, Perfetti Riccardo now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Applied Therapeutics Inc. (NASDAQ:APLT) Chief Medical Officer, Perfetti Riccardo, we have the following information:
SEC Form 4 filing: Nov 20: Sold 1,660 shares at the rate of $19.07 per share. Total worth of this trade was $31,662. Total number of shares owned as of Nov 20 were 0